0.9% Normal Saline (Placebo): Clinical Trials

1 trial of 0.9% Normal Saline (Placebo), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow 0.9% Normal Saline (Placebo): new trials by email Literature Review of 0.9% Normal Saline (Placebo) trials Research Report on 0.9% Normal Saline (Placebo)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial Pain
Botulinum Toxin Type A (BoNT-A), 0.9% Normal Saline (Placebo) - Temporomandibular Disorder
Phase 2RecruitingRiphah International University1182026-08-152026-09-29

Conditions studied

Temporomandibular Joint Disorders (1)

Sponsors

Riphah International University (1)

Countries

Pakistan (1)

Top investigators

Uzair Luqman, FCPS (1)